share_log

International Expansion Still Major Growth Driver For Canadian Cannabis Co. Avant, Reports 4% YoY Increase In Q2 Net Revenue

International Expansion Still Major Growth Driver For Canadian Cannabis Co. Avant, Reports 4% YoY Increase In Q2 Net Revenue

國際擴張仍是加拿大大麻股Avant的主要增長驅動力,報告第二季度淨營業收入同比增長4%。
Benzinga ·  07/17 10:09

Cannabis producer Avant Brands Inc. (TSX:AVNT) (OTCQX:AVTBF) (FRA: 1BUP) reported its financial results on Monday for the second quarter ended May 31, 2024.

大麻生產商Avant Brands Inc.(多倫多證券交易所股票代碼:AVNT)(場外交易代碼:AVTBF)(FRA:1BUP)週一公佈了截至2024年5月31日的第二季度財務業績。

The British Columbia-based company said in a press release that it has achieved "significant financial milestones driven by strategic international expansion and operational improvements."

這家總部位於不列顛哥倫比亞省的公司在一份新聞稿中表示,“在國際戰略擴張和運營改善的推動下,它已經實現了重要的財務里程碑”。

Q2 2024 Financial Highlights

2024 年第二季度財務摘要

  • Gross revenue increased by 5% reaching CA$9.4 million ($6.8 million) compared to the second quarter of 2023, while net revenue rose by 4% over the same period to CA$8.3 million, demonstrating sustained growth driven by robust international demand.
  • International sales rose 26% year-over-year to reach a record CA$3.7 million, now representing 45% of net revenue.
  • Gross loss amounted to CA$1.8 million, compared to a gross profit of CA$3.3 million in the prior year's quarter.
  • Net loss from operations was roughly CA$5 million, compared to a net income of CA$265 000 in the second quarter of fiscal 2023.
  • Net loss and comprehensive loss was CA$3.7 million, compared to a CA$390 000 net loss in the corresponding quarter of 2023.
  • Achieved positive adjusted EBITDA of CA$2.8 million.
  • As of May 31, 2024, the company had CA$74.4 million in total assets, compared to CA$82.5 million as of Nov. 30, 2023.
  • Total liabilities amounted to CA$28.4 million as of May 31, 2024, compared to CA$33.2 million as of Nov. 30, 2023.
  • 與2023年第二季度相比,總收入增長了5%,達到940萬加元(合680萬美元),而同期淨收入增長了4%,達到830萬加元,這表明強勁的國際需求推動了持續增長。
  • 國際銷售額同比增長26%,達到創紀錄的370萬加元,目前佔淨收入的45%。
  • 總虧損爲180萬加元,而去年同期的毛利爲330萬加元。
  • 運營淨虧損約爲500萬加元,而2023財年第二季度的淨收入爲26.5萬加元。
  • 淨虧損和綜合虧損爲370萬加元,而2023年同期的淨虧損爲39萬加元。
  • 調整後的息稅折舊攤銷前利潤爲280萬加元。
  • 截至2024年5月31日,該公司的總資產爲7,440萬加元,而截至2023年11月30日,該公司的總資產爲8,250萬加元。
  • 截至2024年5月31日,總負債爲2840萬加元,而截至2023年11月30日爲3320萬加元。

Read Also: International Expansion Drives Growth For This Canadian Cannabis Producer As It Reports Record Q1 Revenue

另請閱讀:國際擴張推動了這家加拿大大麻生產商的增長,該公司報告了創紀錄的第一季度收入

"Avant Brands is on a strong trajectory, and our Q2 2024 results demonstrate the effectiveness of our strategic initiatives. We are capitalizing on the growing international demand for premium cannabis products, while also achieving record profitability," Norton Singhavon, the company's founder and CEO, said. "With a focus on international markets and operational excellence, we are well-positioned for long-term success."

“Avant Brands走上了強勁的發展軌道,我們2024年第二季度的業績證明了我們戰略舉措的有效性。我們正在利用國際上對優質大麻產品不斷增長的需求,同時也實現了創紀錄的盈利能力。” 該公司的創始人兼首席執行官諾頓·辛哈文說。“我們專注於國際市場和卓越運營,爲取得長期成功做好了充分的準備。”

Fiscal 2024 Outlook

2024 財年展望

The company said it has undertaken a total of nine international agreements fiscal year to date, with products already shipped to one client and shipments pending for a further five clients.

該公司表示,本財年迄今共簽訂了九份國際協議,產品已經交付給一個客戶,還有五個客戶正在等待發貨。

These new clients represent near-term growth potential spanning territories such as Australia, Germany and Israel, along with new opportunities developing in the Czech Republic, Poland, Portugal, Switzerland and the UK.

這些新客戶代表着跨越澳大利亞、德國和以色列等地區的短期增長潛力,同時在捷克共和國、波蘭、葡萄牙、瑞士和英國也呈現出新的機遇。

Read Next

閱讀下一頁

  • Canadian Marijuana Company Reports 5th Consecutive Quarter Of Positive Cash Flow From Operations
  • 加拿大大麻公司連續第五個季度報告運營現金流爲正

To learn more about cannabis stocks, come, join us at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.

要了解有關大麻股票的更多信息,請加入我們,參加將於10月8日至9日在芝加哥舉行的第19屆Benzinga大麻資本會議。點擊此鏈接,立即在價格飆升之前獲取門票。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論